Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Bucky Katt who wrote (15538)	11/17/2003 10:30:19 AM
From: BW	Respond to of 48461

CTE - sweet! add aonther 60+% to my pile. I guess if longnshort is still in this one we have something in common. CardioTech International Receives FDA Clearance for AlgiMed, Advanced Wound Dressing for Bleeding Wounds Monday November 17, 8:30 am ET WOBURN, Mass., Nov. 17 /PRNewswire-FirstCall/ -- CardioTech International, Inc. (Amex: CTE - News) today announced that it has received FDA clearance to market a new line of wound dressings trade named AlgiMed designed for exuding and bleeding wounds. The dressing absorbs wound exude almost instantaneously, and helps control minor bleeding. Advanced wound care is a $1.5 billion market consisting of specialized dressings to treat serious wounds employing the principle of moist wound healing. By maintaining a moist wound healing environment, wounds have been shown to heal faster with reduced pain and minimal scarring. AlgiMed is a sterile wound dressing made of calcium alginate. When the dressing comes in contact with blood, calcium (a potent pro-coagulant) is released, thus stopping bleeding. CardioTech expects to begin sales of this new product in January 2004. AlgiMed complements HydroMed, CardioTech's other wound dressing. HydroMed is an absorbent hydro gel dressing designed for low exuding wounds, while AlgiMed is an alginate dressing designed for moderately exuding and bleeding wounds. CardioTech plans to introduce AlgiMed starting in January 2004. The product will be distributed by CardioTech through its own warehouse facilities in Massachusetts and California. The dressings will be sold through sales representatives in the U.S., and by national distributors overseas.

To: Bucky Katt who wrote (15538)	11/17/2003 11:59:05 AM
From: tsigprofit	Read Replies (1) \| Respond to of 48461

William, I took a little break for 10 days or so. Do you think this may be the correction we've been talking about for months now? I'm still hedged, and sold most (not all) of my rats. Nasdaq has marched right up from March to October - from around 1250 to 2000. 50% retracement would be in the 1600-1650 area. Do you think we might be headed there over the next few months? VIX got to a low (old measure) of around 16.5 - now around 20. Just wondering what you think. I'm basically set now for a downward bias over the next 3-6 months - after that - who knows. One observation: looks like the old saw "Sell in May and go away" didn't work this year at least. May was Nasdaq 1500, so that missed the last 500 Nasdaq points. But, now that we've had the runup this time already, I'm wondering if we may not see a strong market in the traditionally strong November-April period, thoughts? matt